FindTrial
Sign In

A study on plasma level of calcitonin gene-related peptide(CGRP) in patients with polycystic ovary syndrome(PCOS) and its relationship to hormonal and metabolic parameters

A study on plasma level of calcitonin gene-related peptide(CGRP) in patients with polycystic ovary syndrome(PCOS) and its relationship to hormonal and metabolic parameters

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-11001338
Enrollment
Unknown
Registered
2011-04-27
Start date
2009-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

??:NA
PCOS:the relationship of CGRP and IR, BMI, T and LH/FSH

Sponsors

Reproductive and Genetic Hospital of CITIC-Xiangya
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 38 Years

Inclusion criteria

Inclusion criteria: control subjects(n=37): aged between 21-38, regular menstrual cycle between 24-35, sterility factors: uni- or bilateral tubal impotency or male factor.PCOS subjects(n=215): aged between 21-38, PCOS was defined as the existence of at least two of the following three features: oligomenorrhea or amenorrhea (<6 menstrual cycles for each year), hyperandrogenism, and polycystic ovaries.

Exclusion criteria

Exclusion criteria: All subjects had not taken hormonal contraceptives or steroids and taken laparoscopic ovarian drilling within the previous six months.

Design outcomes

Primary

MeasureTime frame
plasma levels of CGR;—

Secondary

MeasureTime frame
the ratio of LH/FSH;IR;plasma levels of T;BMI;—

Countries

China

Contacts

Public ContactZhe Zhang
amanda-zz@126.com+86 13467505047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026